GlucoSet's critical care monitoring solutions enable clinics to reduce complications and cost. The company's real-time, intra-vascular, hydrogel-based continuous glucose monitor delivers constant accurate information on blood glucose levels, making continuous glucose control in the ICU a reality.
Founded in
2011
CEO
Nicolas Elvemo
Invested since
2023